Calidi Biotherapeutics (CLDI) Invested Capital (2021 - 2025)
Calidi Biotherapeutics' quarterly Invested Capital came in at $3.8 million in Q4 2025, up 71.57% year-on-year from $2.2 million in Q4 2024, and down 47.78% quarter-over-quarter from $7.2 million in Q3 2025.
Calidi Biotherapeutics has reported Invested Capital for 5 years, with the latest figure at $3.8 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 71.57% year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $3.8 million (up 71.57% YoY), and the FY2025 full-year result was $3.8 million, up 71.57% from the prior year.
- Invested Capital for Q4 2025 stood at $3.8 million, down from $7.2 million in the prior quarter.
- The five-year high for Invested Capital was $7.3 million in Q1 2025, with the low at -$63.4 million in Q2 2023.
- Average Invested Capital over 5 years is -$20.1 million, with a median of -$11.5 million recorded in 2024.
- Year-over-year, Invested Capital tumbled 10092.55% in 2024 and jumped 175.13% in 2025.
- Tracing CLDI's Invested Capital over 5 years: stood at -$31.6 million in 2021, then plunged by 56.4% to -$49.4 million in 2022, then soared by 83.34% to -$8.2 million in 2023, then surged by 126.61% to $2.2 million in 2024, then jumped by 71.57% to $3.8 million in 2025.
- The last three Invested Capital figures came in at $3.8 million (Q4 2025), $7.2 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Calidi Biotherapeutics | - | - | - | 3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | -9.58 Mn |
| Jun 30, 2024 | -11.54 Mn |
| Mar 31, 2024 | -14.37 Mn |
| Dec 31, 2023 | -8.24 Mn |
| Sep 30, 2023 | -94,000.00 |
| Jun 30, 2023 | -63.44 Mn |
| Mar 31, 2023 | -54.96 Mn |
| Dec 31, 2022 | -49.44 Mn |
| Sep 30, 2022 | -43.93 Mn |
| Jun 30, 2022 | -39.64 Mn |
| Mar 31, 2022 | -37.62 Mn |
| Dec 31, 2021 | -31.61 Mn |